|
SUV39H2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.636800E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.030800E-01 |
| Normal-vs-Stage2 |
4.765800E-01 |
| Normal-vs-Stage3 |
2.866100E-02 |
| Normal-vs-Stage4 |
5.414600E-01 |
| Stage1-vs-Stage2 |
8.334000E-01 |
| Stage1-vs-Stage3 |
1.789400E-01 |
| Stage1-vs-Stage4 |
2.713200E-01 |
| Stage2-vs-Stage3 |
3.172400E-01 |
| Stage2-vs-Stage4 |
3.506800E-01 |
| Stage3-vs-Stage4 |
1.349800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.092600E-01 |
| Normal-vs-AfricanAmerican |
1.340460E-02 |
| Normal-vs-Asian |
3.883400E-01 |
| Caucasian-vs-AfricanAmerican |
4.688000E-02 |
| Caucasian-vs-Asian |
5.764800E-01 |
| AfricanAmerican-vs-Asian |
7.251800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.256600E-01 |
| Normal-vs-Female |
9.709200E-01 |
| Male-vs-Female |
7.884000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.570200E-01 |
| Normal-vs-Age(41-60Yrs) |
6.692400E-01 |
| Normal-vs-Age(61-80Yrs) |
1.082600E-01 |
| Normal-vs-Age(81-100Yrs) |
1.325220E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.426800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.182200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.370800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.914600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.759200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.333000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.822800E-01 |
| Normal-vs-Grade 2 |
4.257600E-01 |
| Normal-vs-Grade 3 |
2.831600E-02 |
| Normal-vs-Grade 4 |
6.344400E-01 |
| Grade 1-vs-Grade 2 |
7.557800E-01 |
| Grade 1-vs-Grade 3 |
3.453200E-01 |
| Grade 1-vs-Grade 4 |
6.004600E-01 |
| Grade 2-vs-Grade 3 |
8.157800E-02 |
| Grade 2-vs-Grade 4 |
4.541400E-01 |
| Grade 3-vs-Grade 4 |
2.240000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.032400E-01 |
| Normal-vs-ccB subtype |
1.058420E-01 |
| ccA subtype-vs-ccB subtype |
1.957220E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.836800E-01 |
| Normal-vs-N1 |
2.898800E-01 |
| N0-vs-N1 |
3.409800E-01 |
|
|
